Willamette Valley Clinical Studies — Eugene, Oregon

Willamette Valley Clinical Studies is a clinical research site located in Eugene, Oregon, United States 97404.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Willamette Valley Clinical Studies has participated in 17 clinical trials with 1 currently active.

Therapeutic areas: Dyslipidemia, Type 2 Diabetes Mellitus, Resistant Hypertension.

Sponsors: Pronova BioPharma, Elcelyx Therapeutics, Inc., Idorsia Pharmaceuticals Ltd..

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Willamette Valley Clinical Studies?

Willamette Valley Clinical Studies has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Willamette Valley Clinical Studies conducted?

Willamette Valley Clinical Studies has 17 clinical trials on record, with 1 currently active. Their work covers Dyslipidemia, Type 2 Diabetes Mellitus, Resistant Hypertension.

Is Willamette Valley Clinical Studies accredited by Crixeo Health?

Yes — Willamette Valley Clinical Studies holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Willamette Valley Clinical Studies?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.